Target intelligence / Profile preview

Phospholipase A2 group XIIB (PLA2G12B)

Target
PLA2G12B
Molecular classification
Enzyme, Secreted phospholipase A2-like protein, Calcium-dependent membrane-associated protein
01

Overview

Phospholipase A2 group XIIB (PLA2G12B) is a member of the secreted phospholipase A2 (sPLA2) gene family but has evolved a distinct, non-catalytic role in regulating triglyceride-rich lipoprotein (TRL) expansion. PLA2G12B is tightly associated with the endoplasmic reticulum (ER) membrane and facilitates the loading of triglycerides into nascent apolipoprotein B-containing lipoproteins, thereby promoting efficient lipid secretion and maintaining cellular lipid homeostasis. Unlike other sPLA2s, PLA2G12B is not actively secreted into the extracellular space but is retained within the ER where it interacts with the membrane and proteins involved in lipoprotein assembly, such as the lipid transfer protein MTP. PLA2G12B is calcium-dependent and contains functional domains including a signal peptide, an ER-retention motif, hydrophobic membrane anchor sequences, and a calcium-binding domain. Mutations disrupting PLA2G12B lead to reduced secretion of triglyceride-rich lipoproteins, excess intracellular lipid accumulation, profound hypolipidemia, and resistance to atherosclerosis in animal models, highlighting its significance in preventing cardiovascular disease and metabolic disorders.

Other names
Group XIIB secretory phospholipase A2-like proteinPLA2G12BPLA2G13FKSG71GXIII sPLA2-likeGXIIBGroup XIII secretory phospholipase A2-like proteinsPLA2-GXIIBGXIIIsPLA2group XIIB secretory phospholipase A2-like proteingroup XIII secreted phospholipase A2phospholipase A2, group XIII
02

Biological functions

Triglyceride incorporation into lipoproteinsLipid partitioning between cellular compartmentsMaintenance of lipoprotein homeostasisFacilitates secretion of triglyceride-rich lipoproteins (TRLs)
03

Disease associations

Cardiovascular disease (role in atherosclerosis)Metabolic disorders (hypolipidemia observed with knockout mutations)Other (lipoprotein-related pathologies)
04

Safety considerations

Potential impact of modulation on lipoprotein homeostasis and cardiovascular riskUnknown long-term consequences of PLA2G12B inhibition (given evolutionary tradeoff in lipid transport vs. atherosclerosis)
05

Biomarkers

Mutations or expression levels of PLA2G12B for predicting risk/resistance to atherosclerosisIntracellular lipid content or TRL expansion capacity as readouts in functional studies

Beyond the preview

Go deeper on Phospholipase A2 group XIIB (PLA2G12B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phospholipase A2 group XIIB (PLA2G12B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call